After FDA rebuff, Nabriva turns its attention to Europe
May 08, 2019 at 11:40 AM EDT
Nabriva is seeking European approval for both intravenous and oral formulations of Lefamulin as a treatment of community-acquired pneumonia in adults.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|